• Spermine as a Precision Tool for Ion-Channel Assays

  2026-09-14

  Spermine is an endogenous polyamine that provides a powerful way to study inward rectifier potassium channel modulation, cellular metabolism, and ion channel regulation. This article develops an assay-focused framework connecting Spermine pharmacology with the CLCC1 nuclear-egress study while clearly separating established evidence from emerging hypotheses.

• DMH1: ALK2 Inhibitor Workflows for Organoids

  2026-09-13

  DMH1 enables selective BMP-pathway perturbation across pancreatic organoid and cancer-model workflows without the broader kinase activity associated with less selective tools. This guide translates the reference study’s organoid strategy into executable dosing, validation, troubleshooting, and NSCLC assay plans.

• TBST: Practical Immunoassay Workflow Guide

  2026-09-12

  This scenario-based guide explains how TBST (Tris-Buffered Saline and Tween 20), SKU K1199, can reduce nonspecific background and standardize antibody-based readouts linked to proliferation, cytotoxicity, and cell-viability studies. It also clarifies compatibility limits, protocol controls, data interpretation, and practical vendor-selection criteria.

• KPT330 and Cas9 mRNA Export in Precision Editing

  2026-09-11

  The reference study identifies selective inhibitors of nuclear export, including KPT330, as indirect CRISPR-Cas9 modulators that reduce editing by disrupting Cas9 mRNA export rather than inhibiting Cas9 protein directly. This mechanism improved the specificity of genome- and base-editing systems in human cells and suggests that controlling the duration of Cas9 expression can complement guide and enzyme engineering strategies.

• Mycophenolic acid in Whole-Blood Immunometabolism

  2026-09-11

  Mycophenolic acid enables controlled dehydrogenase inhibition in fresh whole-blood stimulation assays, linking nucleotide metabolism to cytokine output. This workflow-focused guide covers stock preparation, metabolic perturbation, assay controls, troubleshooting, and extensions into apoptosis and anti-infection research.

• WIP1, p38 MAPK, and Pyroptosis in Sepsis-AKI

  2026-09-10

  The reference study identifies WIP1/PPM1D as a negative regulator of p38 MAPK-driven pyroptosis in renal tubular cells during sepsis-associated acute kidney injury. By combining human tissue observations, mouse models, single-cell sequencing, and HK2-cell experiments, it positions WIP1 inhibition as a mechanistic tool for testing inflammatory cell-death pathways in the kidney.

• EZ Cap™ Human PTEN mRNA (ψUTP) Workflow

  2026-09-10

  Learn how to use EZ Cap™ Human PTEN mRNA (ψUTP) to restore PTEN expression, interrogate PI3K/Akt signaling, and build reproducible mammalian-cell assays. This practical guide connects modified mRNA design with nanoparticle delivery strategies relevant to trastuzumab-resistance research.

• PFHxS Hepatotoxicity via PPARα in Zebrafish

  2026-09-09

  This 2024 study shows that environmentally relevant PFHxS exposure produces liver injury in larval zebrafish and connects the phenotype to PPAR-associated transcriptional disruption. By combining transcriptomics, pathology, biochemical measurements, targeted gene analysis, pharmacological antagonism, and morpholino knockdown, the work provides a mechanistic framework for PFAS toxicology and lipid homeostasis studies.

• Dorsomorphin 2HCl: From AMPK to Translation

  2026-09-09

  Dorsomorphin 2HCl is more than a routine AMPK inhibitor: it can function as a causal stress test for metabolic phenotypes while also opening research paths through BMP signaling, osteogenic differentiation, hepcidin expression regulation, and iron homeostasis. This thought-leadership guide connects the compound’s mechanism with the recent Lactiplantibacillus plantarum P101 liver study and translates those findings into stronger experimental and translational strategies.

• FGF-19, FGFR4, and the Next Frontier in Renal Signaling

  2026-09-08

  WIP1–p38 MAPK–pyroptosis research provides a compelling mechanistic framework for sepsis-associated acute kidney injury, while Recombinant Human FGF-19 offers a controlled way to test whether endocrine FGFR4 signaling intersects with renal inflammatory injury. This article distinguishes established evidence from testable hypotheses and outlines a receptor-aware workflow for translational researchers.

• SU6656 Src Tyrosine Kinases Inhibitor Workflows

  2026-09-08

  SU6656 provides a practical way to interrogate Src-dependent signaling in mitogenesis, megakaryocyte maturation, and radiation response. This evidence-led workflow separates established product applications from testable strategies for iPSC-derived platelet research and radiotherapy sensitization.

• PMSF Workflows for Protein Integrity

  2026-09-07

  Phenylmethanesulfonyl fluoride (PMSF) provides targeted, irreversible serine protease control during protein extraction and Western blot sample preparation. This guide connects practical PMSF handling with modern GSPT1 degrader studies, showing how better lysate preservation can strengthen degradation, signaling, and apoptosis assays without confusing sample protection with mechanism of action.

• Tetracycline Hydrochloride: Assay Workflows

  2026-09-07

  Build more reproducible antimicrobial assays with Tetracycline Hydrochloride by controlling solvent, exposure time, and bacteriostatic readouts. This guide connects Staphylococcus aureus, Propionibacterium acnes, and microbiome applications with practical lessons from rapid ROS-based cancer nanodrug research—without conflating distinct mechanisms.

• EdU Imaging Kits (Cy3): S-Phase Workflow

  2026-09-05

  EdU Imaging Kits (Cy3) turn short DNA-replication pulses into bright, denaturation-free readouts for microscopy and flow cytometry. This practical guide shows how to apply the assay to cholangiocarcinoma drug studies, combination-treatment experiments, genotoxicity testing, and troubleshooting-driven method development.

• ONX-0914 (PR-957) Assay Guide

  2026-09-04

  This scenario-driven guide explains how ONX-0914 (PR-957), SKU A4011, can support interpretable viability, proliferation, and cytokine experiments through selective immunoproteasome inhibition. It covers assay compatibility, solvent handling, dose interpretation, and practical criteria for comparing research-grade products.

557 records 5/38 page Previous Next 12345 下5页 Last page